MedPath

Phathom Pharmaceuticals

Phathom Pharmaceuticals logo
🇺🇸United States
Ownership
Public
Established
2018-01-01
Employees
452
Market Cap
$1B
Website
http://www.phathompharma.com
Introduction

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy Participants

Phase 1
Withdrawn
Conditions
Healthy Participants
Interventions
First Posted Date
2020-09-22
Last Posted Date
2022-03-02
Lead Sponsor
Phathom Pharmaceuticals, Inc.
Registration Number
NCT04558216
Locations
🇺🇸

PPD Development, LP, 7551 Metro Center Drive, Suite 200, Austin, Texas, United States

Evaluation of Effect of Vonoprazan on Midazolam Pharmacokinetics in Healthy Participants

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
First Posted Date
2020-09-11
Last Posted Date
2023-03-17
Lead Sponsor
Phathom Pharmaceuticals, Inc.
Target Recruit Count
20
Registration Number
NCT04545944
Locations
🇺🇸

PPD Development, LP, Austin, Texas, United States

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection

Phase 3
Completed
Conditions
Helicobacter Pylori Infection
Interventions
First Posted Date
2019-11-19
Last Posted Date
2022-04-05
Lead Sponsor
Phathom Pharmaceuticals, Inc.
Target Recruit Count
1046
Registration Number
NCT04167670
Locations
🇺🇸

Carolina Research, Greenville, North Carolina, United States

🇺🇸

Synexus Clinical Research US, Inc. - Anderson, Anderson, South Carolina, United States

🇺🇸

Anaheim Clinical Trials LLC, Anaheim, California, United States

and more 147 locations

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis

Phase 3
Completed
Conditions
Erosive Esophagitis
Interventions
First Posted Date
2019-10-14
Last Posted Date
2022-07-29
Lead Sponsor
Phathom Pharmaceuticals, Inc.
Target Recruit Count
1027
Registration Number
NCT04124926
Locations
🇺🇸

Carolina Research, Greenville, North Carolina, United States

🇺🇸

Central Sooner Research, Norman, Oklahoma, United States

🇺🇸

Biopharma Informatic, LLC, Houston, Texas, United States

and more 149 locations
© Copyright 2025. All Rights Reserved by MedPath